Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
Abreu MT, Davies JM, Quintero MA, Delmas A, Diaz S, Martinez CD, Venables T, Reich A, Crynen G, Deshpande AR, Kerman DH, Damas OM, Fernandez I, Santander AM, Pignac-Kobinger J, Burgueno JF, Sundrud MS.
Abreu MT, et al. Among authors: venables t.
Inflamm Bowel Dis. 2022 Dec 1;28(12):1800-1812. doi: 10.1093/ibd/izac151.
Inflamm Bowel Dis. 2022.
PMID: 35993552
Free PMC article.